High-dose zinc to terminate angina pectoris: A review and hypothesis for action by ICAM inhibition

被引:18
|
作者
Eby, GA
Halcomb, WW
机构
[1] George Eby Res, Austin, TX 78704 USA
[2] William W Halcomb Clin, Mesa, AZ 85206 USA
关键词
D O I
10.1016/j.mehy.2005.06.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We reviewed the literature related to the effects of high-dose zinc in arteriosclerosis-induced angina pectoris. Lipid peroxidation and LDL oxidation are believed to be critical for arteriosclerosis, and consequently angina pectoris. Administration of biologically available zinc was a beneficial treatment in a significant percentage of patients with severely symptomatic, inoperable atherosclerotic disease. In these patients, there was no difference in zinc concentration between patients with and without atherosclerosis in whole blood, erythocytes or hair, but there was a major difference between normal aorta and diseased aortas (40.6 ppm zinc in normal aorta vs. 23.2 ppm zinc in atherosclerotic aorta, 40.6 ppm zinc in normal aorta vs. 19.4 ppm zinc in atherosclerotic aneurysm aorta, and no difference between normal and aneurysm aorta), although copper was low in aneurysm aorta. Medication with high-dose zinc sulfate to raise zinc serum concentrations from 95 to 177 mu g/dl resulted in objective improvement in 12 of 16 of these patients, including a patient that also had Reynard's disease. Long term environmental exposure to zinc resulted in a 40% reduction in the incidence of angina of effort compared to people not exposed to environmental zinc (P < 0.01) and a 40% reduction in the incidence of probable ischemia in exercise (P < 0.001). Lead had no effect while cadmium exposure resulted in more than tripling the incidence of angina of effort (P < 0.001). The antioxidative action of zinc prevents oxidation of LDL cholesterol and consequently stops the main mechanism of atherogenesis. Zinc blocks calcium and its several actions on atherogenesis. Increased amounts of cytotoxic cytokines such as TNF-alpha, IL-beta and IL-8, often produced in the elderly, are blocked by high-dose zinc. We hypothesize that higher serum concentrations of LDL cholesterol resulting from administration of 300 mg of zinc per day is caused by a release of low density cholesterol from cardiovascular tissues, beneficially flushing it into the serum where it is readily observed, thus decreasing arteriosclerosis, increasing circulation, terminating angina pectoris and restoring more youthful cardiac function. Although prevention of cholesterol-induced arteriosclerosis by zinc is predicted from findings related to oxidative stress and lipid peroxidation, removal of LDL might be attributable to action of ionic zinc on ICAM inhibition. In stark contrast to current practice, high-dose zinc should be considered as basic in the strategy of prophylaxis and therapy of the atherosclerosis process to terminate angina pectoris and restore youthful cardiac function. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:169 / 172
页数:4
相关论文
共 50 条
  • [41] High-dose phenomena in zinc-implanted silicon crystals
    Simov, S
    Kalitzova, M
    Karpuzov, D
    Yankov, R
    Angelov, C
    Faure, J
    Bonhomme, P
    Balossier, G
    JOURNAL OF APPLIED PHYSICS, 1996, 79 (07) : 3470 - 3476
  • [42] DOSE-RESPONSE AND DURATION OF ACTION OF ORAL ISOSORBIDE DINITRATE DURING SUSTAINED THERAPY IN ANGINA-PECTORIS
    THADANI, U
    DARKE, A
    FUNG, HL
    PARKER, JO
    AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (02): : 478 - 478
  • [43] EXCESS-SUBSTRATE INHIBITION IN ENZYMOLOGY AND HIGH-DOSE INHIBITION IN PHARMACOLOGY - A REINTERPRETATION
    KUHL, PW
    BIOCHEMICAL JOURNAL, 1994, 298 : 171 - 180
  • [44] NONSPECIFIC ACTION OF GLUCOCORTICOSTEROIDS AFTER HIGH-DOSE PULSE THERAPY
    HIRSCHELMANN, R
    SCHADE, R
    BURGER, W
    BEKEMEIER, H
    AGENTS AND ACTIONS, 1990, 31 (1-2): : 148 - 151
  • [45] Platelet-dependent action of high-dose factor VIIa
    Hoffman, M
    Monroe, DM
    Roberts, HR
    BLOOD, 2002, 100 (01) : 364 - 365
  • [46] SLE ANTICOAGULANT - TRANSIENT INHIBITION BY HIGH-DOSE IMMUNOGLOBULIN INFUSIONS
    MCVERRY, BA
    SPEARING, R
    SMITH, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 579 - 580
  • [47] EFFECT OF A HIGH-DOSE OF VASOPRESSIN ON AN INHIBITION AVOIDANCE-RESPONSE
    CRINE, AF
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1982, 6 (03): : 265 - 268
  • [48] Retinal risks of high-dose ornithine supplements: a review
    Hayasaka, Seiji
    Kodama, Tatsuo
    Ohira, Akihiro
    BRITISH JOURNAL OF NUTRITION, 2011, 106 (06) : 801 - 811
  • [49] High-dose chemotherapy in breast cancer - a critical review
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 24 - 25
  • [50] Status of high-dose chemotherapy for breast cancer: A review
    Nieto, Y
    Champlin, RE
    Wingard, JR
    Vredenburgh, JJ
    Elias, AD
    Richardson, PR
    Glaspy, J
    Jones, RB
    Stiff, PJ
    Bearman, SI
    Cagnoni, PJ
    McSweeney, PA
    LeMaistre, CF
    Pecora, AL
    Shpall, EJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (05) : 476 - 495